The specific capsular polysaccharide of type 45 Streptococcus pneumoniae was isolated in pure form by chemical and chromatographic methods and found to be a high-molecular-weight, glycosidically linked polymer of a hexasaccharide repeating unit composed of D-galactose (2 mol), L-rhamnose (1 mol), N-acetyl-Dglucosamine (1 mol), N-acetyl-D-galactosamine (1 mol), N-acetyl-L-fucosamine (1 mol), and phosphate (1 mol). 2, 3, 4, 6, 8, 12, 14, 19, 23, 25, 51, and 56 
Interest in the purification, chemical compositions, physicochemical characteristics, structures, and immunological properties of the typespecific capsular polysaccharides of Streptococcus pneumoniae has increased since the U.S. government recently awarded a license for the manufacture and sale of a pneumococcal vaccine composed of 14 of the 84 serologically defined (13) pneumococcal type polysaccharides. A precise definition of each type polysaccharide is of value for determining the purity of each vaccine component and also allows official criteria to be established (5) based on immunological, chemical, and physical properties.
The formulation of a pneumococcal vaccine is based on surveys of the pneumococcal types responsible for the major proportion of human infections in a particular region (1, 2 Fig. 2. the line against the myeloma protein was removed by flooding the plate with dilute phosphorylcholine solution.
The crude type 45 polysaccharide (110 mg) was fractionated by DEAE-Sephadex chromatography to yield two main fractions. The first fraction (22 mg), which eluted from the column in the tris(hydroxymethyl)aminomethane-hydrochloride equilibration buffer (tubes 3 through 7) (Fig. 2) , did not give a precipitin line on immunodiffusion against type 45 antisera but gave a strong line against the myeloma protein (Fig. 1) . The fraction had [a],, = +21.80 (c = 0.1 in water) and on analysis was found to be composed essentially of three neutral glycoses, two aminoglycoses, phosphate, and choline (Table  2 ). Polysaccharide eluting from the column in the sodium chloride gradient was collected in two parts: P1 (21 mg) (tubes 19 through 23) and P2 (15 mg) (tubes 24 through 30). Fractions P1 and P2 gave strong precipitin lines against type 45 pneumococcal antisera and against the myeloma protein (Fig. 1 ). P1 and P2 had [a]D =-1°a nd -4°(c = 0.1 in water), respectively, and analysis showed them to have similar compositions (Table 2 ) of four neutral glycoses and three aminoglycoses.
Type 45 specific polysaccharide was obtained in pure form in 61% yield by specific precipitation as its cetyltrimethylammonium salt complex. The polysaccharide regenerated from the complex on DEAE-Sephadex chromatography did not give any material eluting in the equilibration buffer, but gave a sharp peak (Fig. 3 (7) . Acetylation of the reduced glycose gave tetra-Oacetyl-2-acetamido-2-deoxy-L-fucitol, which gave on GLC a single peak with TGNAC = 0.31, corresponding in retention time to an authentic derivative.
With gel filtration on Sepharose 4B, the type 45 polysaccharide was eluted as a single peak with Kd = 0.05. After treatment of the polysaccharide (10 mg) with N sodium hydroxide (1 ml) for 1 h at 100°C, the neutralized (AcOH) solution on Sepharose 4B gel filtration showed a broad peak eluting at Kd = 0.20, but no other lowermolecular-weight glycose containing products were detected.
The infrared spectrum of the type 45 polysaccharide showed broad absorption around 3,300 cm-' (hydroxyl) and peaks at 2,900 (C-H), 1,650, and 1,560 cm-l characteristic of Ca=O and N-H amide bonds of N-acetyl groups. The proton magnetic resonance spectra of the polysaccharide showed a dublet at 8 1.37 (3H, J5,6 = 6 Hz) from the terminal methyl of L-fucosamine 45 pneumococcus, but gave a strong line against a myeloma protein (12) specific for phosphorylcholine. The polysaccharide material had a positive specific optical rotation and on analysis was found to be composed of fucose, mannose, galactose, glucosamine, and galactosamine together with small amounts of fucosamine.
Elution of the DEAE-Sephadex column, from which the nonspecific polysaccharide material had been removed, with a gradient of sodium chloride afforded polysaccharide (ca. 62%) fractions which gave a strong precipitin line in immunodiffusion against type 45 antiserum and less strong lines against the myeloma protein (Fig. 1) . Two separate fractions (P1 and P2) collected from the salt gradient elution showed negative specific optical rotations and had similar analyses, being composed of rhamnose, galactose, glucosamine, galactosamine, and fucosamine together with small amounts of mannose and fucose (Table 1) .
Although the nonspecific polysaccharide material (N) and the salt gradient polysaccharide (P1 and P2) shared glucosamine, galactosamine, and galactose as major glycose constituents, the nonspecific material (N) had significantly higher content of mannose and fucose and lacked fucosamine and rhamnose, whereas the polysaccharide fractions (P1 and P2) reacting with the type 45 antiserum contained rhamnose and some fucose but no mannose.
Although the DEAE-Sephadex fractionation gave clear evidence that the crude type 45 polysaccharide preparation was a mixture containing at least 38% nonspecific carbohydrate contaminant, the small amounts of mannose and fucose found in the salt-eluted fractions considered together with the weak ability of these fractions to react with the myeloma protein specific for phosphorylcholine suggested, that fractions P1 and P2 were not pure type 45 It was found that pure type 45 polysaccharide could be obtained from the crude polysaccharide preparation by specific precipitation as its cetyltrimethylammonium salt complex. The polysaccharide regenerated from the complex was obtained in about 60% yield based on original material. DEAE-Sephadex chromatography under the conditions previously described did not yield any material eluting with the buffer but, on elution with a gradient of sodium chloride, a single peak of homogeneous composition was obtained. The type 45 polysaccharide obtained by the insoluble complex had a low negative specific optical rotation ([a]D =-6.7°) and gave a precipitin line in immunodiffusion against the type 45 antiserum but not against the myeloma protein, indicating the absence of phosphorylcholine from the material. Furthermore, the material did not contain any mannose or fucose, which were contaminants in the P1 and P2 fractions. Further fractionation of this material could not be achieved, and it is considered that it represents type 45 pneumococcal specific polysaccharide. Trace amounts of glucose found in the material probably arise from a very minor amount of contaminant, and it is probable that glucose does not form a constituent of the specific polysaccharide.
Analysis of the type 45 polysaccharide obtained by the insoluble complex was found to be composed of L-rhamnose (1 mol), D-galactose (2 mol), N-acetyl-D-glucosamine (1 mol) , N-acetyl-D-galactosamne (1 mol), N-acetyl-L-fucosamine (1 mol), and phosphate (1 mol). From the infrared and proton magnetic resonance spectral information, it appears that the aminoglycose constituents in the polysaccharide are N-acetylated, and these data, considered in conjunction with the fact that gel filtration indicates the polysaccharide to have a high molecular weight, suggest that the polysaccharide is a polymer of a repeating hexasaccharide unit. The observed stability of the polymeric structure on treatment with hot alkali indicates that the repeating units are not joined through phosphate ester linkages and that probably all the linkages in the polysaccharide are glycosidic.
At this time it is not possible to say what structural features of the polysaccharide are responsible for its serological specificity. The occurrence of three aminoglycose in a pneumococcal polysaccharide is unusual, and it is of interest that the type 46 pneumococcus specific polysaccharide contains the same three aminoglycoses (4) together with D-galactose as the only neutral glycose but, despite this similarity in compositions, there is no cross-reaction between the type 45 and 46 polysaccharides and their specific antisera.
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